Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “ETHYLENE OXIDE”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 163 records · Page 9Linked to original sources

Interaction of tumor and normal blood cells with ethylene oxide and propylene oxide block copolymers.

Ethylene oxide and propylene oxide block copolymers (pluronics) are widely known as agents that promote drug penetration across biological barriers. We have studied the interaction of normal and malignant blood cells with pluronics L61 and P85 that have different hydrophobicity. SP2/0 myeloma cells accumulated pluronics while normal cells adsorb most of the polymer on the surface. Interaction of pluronics with cells resulted in drastic changes of membrane microviscosity. Tumor cell membrane microviscosity decreased after pluronics adsorption, in contrast to normal cells, whose membrane microviscosity was enhanced. We suppose that sensitivity of tumor cell membrane microviscosity to the pluronics action correlates with its permeability for molecular substances.

Animals↗

[Increased frequency of sister chromatid exchange in persons occupationally exposed to ethylene oxide].

Mutagenic effects of ethylene oxide have been demonstrated by short-term testing in vitro and in vivo in several organisms. Its oncogenic activity for man has been suspected and recently supported by experiments in mice. Exposure can occur during ethylene oxide gas sterilization of medical materials. We have tested effects on chromosomes by estimating sister chromatids exchange (SCE) frequency. Our results, reported here, show that exposure to this substance during work is followed by a very highly significant increase of SCE frequency as compared with controls. Thus, the SCE test may, under particular conditions, represent a reliable test for exposure to certain toxic agents.

Adult↗

Genotoxic effects of ethylene oxide and propylene oxide in mouse bone marrow cells.

Ethylene oxide and propylene oxide are high-volume reactive alkylating agents used primarily as intermediates in the chemical industry. Studies were undertaken to investigate the ability of these alkylating agents to induce chromosomal aberrations, micronuclei and sister-chromatid exchanges in mouse bone marrow cells. The mice were exposed to these chemicals by intraperitoneal injection. The data show that both compounds are effective in inducing chromosomal alterations. Our studies confirm the findings reported by different investigators that ethylene oxide is more cytotoxic than propylene oxide. This difference is to a large extent due to a faster detoxification of propylene oxide than of ethylene oxide.

Animals↗

Inhibition of creatine kinase activity by ethylene oxide.

Exposure of rats to 500 ppm ethylene oxide for six hours a day, three times a week, for 12 weeks, lowered serum creatine kinase activity by more than 40%. The only other change was a slightly decreased triglyceride concentration. After four weeks of exposure, neither aspartate aminotransferase nor lactate dehydrogenase activity in brain, spinal cord, and muscle was affected but creatine kinase activity was clearly inhibited. In vitro, ethylene oxide inhibited creatine kinase activity in brain homogenate and in a purified muscle enzyme preparation. Dithiothreitol did not counteract the effect of ethylene oxide. Though the amount of sulphydryl groups in purified creatine kinase was decreased considerably by exposure to ethylene oxide, the enzyme still showed moderate activity. Thus ethylene oxide inhibits creatine kinase activity in vivo and in vitro and the inhibition appears to be unrelated to the disruption of sulphydryl groups in the enzyme.

Animals↗

Reproductive and developmental risks from ethylene oxide: a probabilistic characterization of possible regulatory thresholds.

Ethylene oxide is a gas produced in large quantities in the United States that is used primarily as a chemical intermediate in the production of ethylene glycol, propylene glycol, non-ionic surfactants, ethanolamines, glycol ethers, and other chemicals. It has been well established that ethylene oxide can induce cancer, genetic, reproductive and developmental, and acute health effects in animals. The U.S. Environmental Protection Agency is currently developing both a cancer potency factor and a reference concentration (RfC) for ethylene oxide. This study used the rich database on the reproductive and developmental effects of ethylene oxide to develop a probabilistic characterization of possible regulatory thresholds for ethylene oxide. This analysis was based on the standard regulatory approach for noncancer risk assessment, but involved several innovative elements, such as: (1) the use of advanced statistical methods to account for correlations in developmental outcomes among littermates and allow for simultaneous control of covariates (such as litter size); (2) the application of a probabilistic approach for characterizing the uncertainty in extrapolating the animal results to humans; and (3) the use of a quantitative approach to account for the variation in heterogeneity among the human population. This article presents several classes of results, including: (1) probabilistic characterizations of ED10s for two quantal reproductive outcomes-resorption and fetal death, (2) probabilistic characterizations of one developmental outcome-the dose expected to yield a 5% reduction in fetal (or pup) weight, (3) estimates of the RfCs that would result from using these values in the standard regulatory approach for noncancer risk assessment, and (4) a probabilistic characterization of the level of ethylene oxide exposure that would be expected to yield a 1/1,000 increase in the risk of reproductive or developmental outcomes in exposed human populations.

Animals↗

[Ototoxic study spiral ganglion neurons in the pig guinea with ethylene oxide remained in absorbable gelatin sponge].

OBJECTIVE: To measure ethylene oxide remained in absorbable gelatin sponge, and to observe change of ultrastructure in spiral ganglion neurons after deposited in otic vesicle of pig guinea with ethylene oxide sterilized absorbable gelatin sponge. METHOD: To use comparative colour technique measuring ethylene oxide remained in absorbable gelatin sponge, by means of transmission electron microscope to observe change of ultrastructure in spiral ganglion neurons after 3 months deposited in otic vesicle of pig guinea with ethylene oxide sterilized absorbable gelatin sponge. RESULT: The mean value of ethylene oxide remained in absorbable gelatin sponge were 438.32 mg, while nation standard are less 10 mg, FDA standard(1978) less 25 mg. ultrastructural appearance showed condensed matric electron dense of spiral ganglion mitochondria and dark crista of mitochondria, vacuolated cytoplasm. Ultrastructural observation also demonstrated dissolution or necrosis of ganglion cells, satellite cells, and vacuolated myelin. These changes were near Donson reported(1997) intracochlear perfusion with aminoglycosides. CONCLUSION: The mean value of ethylene oxide remained in absorbable gelatin sponge were 40 times nation standard. Toxic changes of ethylene oxide remained in absorbable gelatin sponge in spiral ganglion neurons were similar to intracochlear perfusion with aminoglycosides.

Animals↗

Ethylene oxide sterilisation--is it safe?

Tests show that ethylene oxide penetrates and can sterilise long narrow tubes in a hospital ethylene oxide steriliser. Residual ethylene oxide levels in plastic tubing after sterilisation have been estimated. Although initially the levels were very high, storage for four days at room temperature reduced them to a safe level. If adequate controls of the sterilising process and storage are carried out, sterilisation by ethylene oxide is considered to be safe for new plastics and clean equipment.

Ethylene Oxide↗

Biologic markers in hospital workers exposed to low levels of ethylene oxide.

Operators of hospital sterilizers that use ethylene oxide were studied to determine if there was a relationship between exposure and a battery of biological markers. A total of 73 workers from nine hospitals in the United States (U.S.) and one hospital in Mexico City was evaluated for ethylene oxide exposure during four months prior to collection of peripheral blood. The frequency of hemoglobin adducts (p = 0.0006) and sister-chromatid exchanges (SCEs) (p = 0.002) increased with cumulative exposure to ethylene oxide in U.S. subjects when controlling by regression analysis for various confounding factors, including cigarette smoking. Hemoglobin adducts, but not SCEs, were also increased in Mexican subjects (p = 0.0012). Chromosomal micronuclei showed no consistent relationship with exposure. The U.S. study participants were classified by four-month cumulative exposure levels of 10 ppm-h (n = 8), greater than 0 to 32 ppm-h (n = 32) and greater than 32 ppm-h (n = 11) of ethylene oxide exposure. The group with an exposure of greater than 32 ppm-h had an increased frequency of hemoglobin adducts (p = 0.002) and SCEs (p = 0.0001) compared to the nonexposed group. The estimated mean of the 8-h time-weighted average (8-h TWA) exposure levels for the highest U.S. exposure group (greater than 32 ppm-h) was 0.16 +/- 0.007 ppm (mean +/- SD). A similar exposure-related differential was observed in the Mexican subjects for hemoglobin adducts (p = 0.04) but not for SCEs. The latter finding may have been due to longer shipping times for the specimens in the cytogenetic assays. The estimated mean of the 8-h TWA exposure levels for the highest Mexican exposure group (greater than 32 ppm-h) was 0.48 +/- 0.08 ppm. This study is the third to suggest that exposures less than the U.S. OSHA standard of 1 ppm 8-h TWA result in biochemical and biologic changes. It is not known whether these changes may be indicative of increased risk of disease; however, they do appear to reflect exposure to relatively low levels of ethylene oxide. The exact meaning of these changes is unknown.

Adult↗

[Mutagenic and cytotoxic effect of ethylene oxide on human cell cultures (author's transl)].

Certain ethylene-oxide residues in sterilized equipment can cause toxic effects in patients. Mutagenic effects of ethylene-oxide have also been described in experimental animals, plants, and bacteria. In our studies an increase of sister chromatid exchange (SCE's) served as indicator for a mutagenic effect of this substance. We cultivated fibroblasts of healthy volunteers and added liquid ethylene oxide in concentrations of 3.6 to 3600 ppm to them. In additional cell cultures we placed endotracheal tubes containing 12 to 3900 ppm ethylene oxide residues on top of the cell layers. After 24 h reaction time the cell cultures were read microscopically and the SCE ratios determined also. Liquid ethylene oxide in concentrations of 360 and 3600 ppm caused a total destruction of the cells. At 36 ppm the cells remained alive. This concentration produced a significant rise of the SCE rate from 12.53 to 16. Tubes with residues of 200 to 600 ppm ethylene oxide brought about a consistent rise of the SCE ratio in the sense of a dose-response relationship. Ethylene oxide has besides its toxic reaction a mutagenic effect upon human fibroblasts. Many other chemical substances have mutagenic potencies also. For safety reasons ethylene oxide sterilized equipment should be aerated before its use as completely as possible.

Cell Survival↗

[Absorption and desorption of ethylene-oxide in anaesthesia-supplies (author's transl)].

After ethylene oxide sterilization unwanted side effects are possible if the sterilized materials are not aerated sufficiently. The desorption of ethylene oxide depends upon many factors. Some of these are the composition of the sterilized materials and the various aeration provisions. It is nearly impossible to make general aeration recommendations because almost each item has different characteristics in regard to the absorption and desorption of ethylene oxide. We investigated the ethylene oxide residues in endotracheal tubes, nasal and oropharyngeal airways of various manufacturers as well as breathing tubes and bags of the Rüsch Company. For sterilization we used two DMB STERIVIT high pressure sterilizers, one Webeco ATOMAT 18, one Webeco ATOMAT 170 and one STERI-VAC 400 B Sterilizer of the 3 M Deutschland Company which operated under a low pressure system. For determination of the residues wer performed a total of about 1000 gaschromatographic analyses. The materials were aerated for 7-10 days at room temperature of 22 to 25 degrees C. IOn addition we perfused children PVC endotracheal tubes with 3 liter/min N2O/O2. By this considerable higher amounts of ethylene oxide were released than in quiet room air. The following recommendations can be made: Portex Blue Line and Rüsch Rüschelit acult tubes should aerate for 10 days. For Portex Blue Line children tubes a shorter time will be sufficient. Portex "green"PVC and Rüsch red rubber tubes retained less ethylene oxide than Blue Line and Rüschelit tubes. Portex oral airways must be vented for 10 days. Rüsch breathing tubes and bags can be used after 48 hours. The recommended aeration time must be observed precisely. Modern heated aerators with continuous air exchange accelerate the degassing process considerably.

Anesthesiology↗

Microwave desorption: a combined sterilizer/aerator for the accelerated elimination of ethylene oxide residues from sterilized supplies.

Ethylene oxide gas is widely used in medical and related facilities for low-temperature sterilization of surgical devices. Evidence of its toxicity and, in particular, its mutagenicity and carcinogenicity provide sufficient reasons for caution in its use and for minimizing exposure. Little advancement has been made in the removal of ethylene oxide residuals from plastics into which the gas is heavily absorbed during sterilization, despite the fact that the gas has been used for 20 years or more. This article describes a novel process (PCT Application/GB85/00509) in which microwave irradiation of ethylene oxide-sterilized materials is utilized to enhance the rate at which the gas is desorbed. The experimental apparatus is described, and an explanation of the effect of microwaves on the energy of activation for diffusion is given. Data are presented in support of the authors' claim of a 400% improvement in the efficiency of the new process over conventional aeration procedures. The advantages and economy of an integrated sterilizer/microwave-enhanced desorber are discussed in the context of the implications that arise from the current regulatory debate.

Air↗

NTP Toxicology and Carcinogenesis Studies of Ethylene Oxide (CAS No. 75-21-8) in B6C3F1 Mice (Inhalation Studies).

Ethylene oxide is a major industrial chemical used primarily as an intermediate in the manufacture of other chemicals; e.g., ethylene glycol, a major component of automotive and other antifreeze products. Exposure to ethylene oxide is greatest in the health care industry, where an estimated 75,000 workers are potentially exposed. Ethylene oxide was nominated for toxicology and carcinogenesis studies in B6C3F1 mice because of its extensive production; the potential for human exposure in the workplace, from medical devices, or from food; the positive results of genetic toxicology assays; and the previous use of only F344/N rats in inhalation carcinogenicity studies. Two inhalation studies reported in 1984 by Snellings et al. and by Lynch et al. demonstrated carcinogenic responses in F344/N rats. Results were similar in both studies and consisted of increased incidences of mononuclear cell leukemia, peritoneal mesotheliomas, and primary brain tumors. Experimental Design: Toxicology and carcinogenesis studies of ethylene oxide (greater than 99% pure) were conducted by exposing groups of 50 B6C3F1 mice of each sex to air containing 0, 50, or 100 ppm ethylene oxide, 6 hours per day, 5 days per week for 102 weeks. These doses were selected because, in 14-week studies, all mice exposed at 600 ppm died within 1 week, and all mice exposed at 400 ppm died by week 4. Rhinitis was observed in both sexes exposed at 200, 400, and 600 ppm as was renal tubular degeneration in both sexes at 100, 200, and 400 ppm. The latter effects observed at 100 ppm were slight and deemed not to be life threatening in 2-year studies. Two-Year Studies: Survival of exposed and control mice was comparable in the 2-year studies (male: control, 28/50; low dose, 31/50; high dose, 34/50; female: 25/50; 24/50;31/50). Final mean body weights in exposed mice were 95%-102% of those of the controls. No compound-related clinical signs were observed. Those neoplastic lesions that occurred at elevated incidences in mice exposed to ethylene oxide are reported in the following table (see page 6 of the Technical Report). In male mice, alveolar/bronchiolar carcinomas, alveolar/bronchiolar adenomas, and papillary cystadenomas of the harderian gland occurred with positive trends. In female mice, alveolar/bronchiolar adenomas, alveolar/bronchiolar carcinomas, papillary cystadenomas of the harderian gland, malignant lymphomas, and uterine adenocarcinomas occurred with positive trends. Mammary gland tumors also were increased in exposed female mice. Data Audit: An audit of the experimental data was conducted for the 2-year studies of ethylene oxide. No data discrepancies were found that influenced the final interpretations. Conclusions: Under the conditions of these 2-year inhalation studies, there was clear evidence of carcinogenic activity for B6C3F1 mice as indicated by dose-related increased incidences of benign or malignant neoplasms of the lung and benign neoplasms of the harderian gland in both male and female B6C3F1 mice following exposure to ethylene oxide vapors at 50 and 100 ppm. In female mice, ethylene oxide caused additional malignant neoplasms of the uterus, mammary gland, and hematopoietic system (lymphoma). Synonyms: oxirane; EO; ETO; dihydrooxirene; dimethylene oxide; 1,2-epoxyethane; oxane; a,beta-oxidoethane

Journal Article↗

Dermatologic hazards from ethylene oxide.

The more recent application of ethylene oxide as a gas sterilizing agent for medical supplies has introduced new problems for this old chemical. Not only is ethylene oxide a potent skin irritant but also delayed hypersensitivity and immediate hypersensitivity have been reported, In this article, chemical properties of this agent and sources of industrial exposure are discussed, and the literature regarding ethylene oxide dermatitis is reviewed.

Burns, Chemical↗

Dose-dependent reduction of bone inductive properties by ethylene oxide.

Sterilisation of demineralised bone matrix with ethylene oxide has been claimed to destroy the ability of bone matrix to induce new bone formation on intramuscular implantation. Other workers have routinely used ethylene oxide sterilised bone matrix for assays in rodents without detrimental effects. We studied the effects of various lengths of exposure to ethylene oxide gas, and found that bone induction properties are destroyed in a dose-dependent manner. After a short exposure, bone induction properties were moderately diminished. However, this short ethylene oxide treatment did not kill Bacillus subtilis spores. A sterilisation procedure that killed these spores rendered the implants incapable of bone-induction.

Animals↗

New scientific arguments for regulation of ethylene oxide residues in skin-care products.

Ethylene oxide (EO) occurs as a contaminant of skin-care products because current commercial preparations of polyglycol ethers may contain ethylene oxide monomer residues, up to the order of 1 ppm. Using current regulatory worst-case assumptions, the presence of EO in skin-care products might lead to a maximal human daily external ethylene oxide dose of about 2.8 micrograms, and a consecutive maximal daily absorbed dose of 0.39 microgram. Two methods of toxicokinetic analysis have been used to compare this possible EO load by use of skin-care products with the inevitable load of EO which is produced endogenously in the organism. On the basis of a previous assessment of the endogenous production of ethylene and ethylene oxide (Filser et al. 1992) it is inferred that the absorbed EO dose of 0.39 microgram is about 1/30 of the unavoidable human endogenous load by endogenous EO. Alternatively, for a second calculation molecular dosimetry data have been used which were based on experimental quantification of the hydroxyethyl adduct of EO to the N-terminal valine of hemoglobin (HOEtVal) in rats. If the worst-case assumptions for human EO absorption from skin-care products are transferred to the rat species, the associated internal EO doses are about 1/110 of the internal EO doses which were calculated from the background HOEtVal concentrations observed in untreated animals. The divergence between both lines of calculation is mainly due to differences in HOEtVal background concentrations between man and rat.(ABSTRACT TRUNCATED AT 250 WORDS)

Animals↗

Mutational consequences of exposure to ethylene oxide.

Additional restrictions on exposure to ethylene oxide, an effective and widely-used sterilant, have recently been proposed (EPA, 1978). Substantial amounts of evidence indicate that ethylene oxide is mutagenic. The data from sub-mammalian systems, including demonstrations of point and chromosomal mutations in bacterial and eukaryotic systems, and from a limited number of studies in mammalian systems are reviewed. The accumulated information, and its context of current guidelines for mutagen testing, are considered in terms of extrapolation to evaluation of potential risk to exposed humans. The available evidence does not appear sufficient to condemn ethylene oxide as a human mutagen at currently acceptable exposure levels.

Animals↗

Ethylene oxide: evidence of human chromosomal effects.

Ethylene oxide is a known mutagen as indicated by short-term testing in vitro and in vivo. Occupational exposure can occur during ethylene oxide gas sterilization of materials for hospital and other use. To study the problem in a hospital sterilization facility where occupational exposure was suspected, epidemiologic, analytic and bioassay tools were employed. All persons whose work activities involved some aspect of the sterilization process were considered exposed to the gas. Within this group of symptomatic and asymptomatic individuals, chronic and incidental exposure was documented by clinical history. Sister chromatid exchanges were studied in lymphocytes cultured from exposed individuals as well as comparable controls. Four chronically exposed persons who reported upper respiratory and neurologic symptoms were studied in some detail. This group showed significantly increased sister chromatid exchange at three weeks and again at eight weeks after the last known exposure. Another group of eight persons with fewer complaints studied as late as the ninth week showed significantly increased exchanges. Incidental exposure may also increase sister chromatid exchange. The measured maximum concentration of ethylene oxide in the sterilizer room was 36 ppm (within standards set by the Occupational Safety and Health Administration).

Chromosome Aberrations↗

Lipid peroxidation and the metabolism of glutathione in rat liver and brain following ethylene oxide inhalation.

The effects of repeated exposure to ethylene oxide on lipid peroxidation and glutathione metabolism in both rat liver and brain were examined. Increased levels of malondialdehyde (MDA) in the liver were observed after 6 and 13 weeks of exposure to ethylene oxide. The increased level of MDA observed in the hepatic homogenates of the treated rats reflected that of the microsomal fraction. On the other hand, no change in the level of MDA was detected in the brain of rats either at a 6- or 13-week treatment. Glutathione reductase activity was found to decrease at 6 or 13 weeks in liver and brain of treated rats. Both reduced and oxidized forms of glutathione in homogenates of liver and brain obtained from treated rats were, however, similar to those of the control at 40 h after the last exposure in individual experiments. To elucidate the cause of lipid peroxidation, the time course of glutathione content after exposure with ethylene oxide were studied in more detail. Significant decreases in both GSH and GSSG content in these organs were detected shortly after exposure to ethylene oxide and their levels recovered gradually with time and reached the control values at 40 h in the liver, although the changes were less significant in the brain as compared with those in the liver. These results suggest that enhancement of lipid peroxidation in the microsomal fraction of the liver after repeated exposure to ethylene oxide may possibly arise from repeated depletions of glutathione to certain critical levels and less removal of lipid peroxidation.

Administration, Inhalation↗